NIH Clinical Center - NIDDK

Bethesda, Maryland 20892

0 studies enrolling now · 1 studies all time

What they study most

Focal Segmental Glomerulosclerosis, Minimal Change Disease, Nephrotic Syndrome

Studies at this site

• Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) — Completed